Compare Sunrun Inc (RUN) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sunrun Inc vs 10X Genomics Inc — how do they compare? Sunrun Inc trades at $8.79 (market cap $2.12B), while 10X Genomics Inc trades at $67.74 (market cap $8.77B). The key difference: 10X Genomics Inc is far larger — about 4.1× Sunrun Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| RUN | TXG | |
|---|---|---|
Market Cap | $2.12B | $8.77B |
Sector | Technology | Health |
52-Week High | $21.41 | $67.29 |
52-Week Low | $8.37 | $11.34 |
Enterprise Value | $16.64B | $8.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sunrun (RUN) trades at $9.22, up 3.71% in the last session, with a bearish technical outlook despite recent earnings beats. The stock shows low valuation multiples (P/E of 5.99, P/S of 0.69) and strong analyst support (62% buy ratings), but faces headwinds from negative operating cash flow and high debt. Recent news highlights guidance cuts and solar tariff impacts, while storage growth offers a potential catalyst.
The outlook is mixed: attractive valuations and storage partnerships support upside to the $14.70 consensus target, but profitability pressures and cash flow challenges pose risks. Investors should weigh low multiples against execution risks in a competitive solar market.
TXG trades at $65.60, up 4.71% today, with a bullish technical signal and recent earnings beats. The stock shows improving fundamentals, with 2025 revenue at $642.82M and net loss narrowing to -$43.54M. Positive sentiment is driven by patent wins, Atera platform demand, and institutional interest, though valuation metrics like P/S of 13.58 and EV/EBITDA of 142.2 remain elevated.
Outlook is cautiously optimistic with upside potential from Atera execution, but risks include high valuation, persistent losses, and competitive pressures. Analyst consensus is mixed with a $50.56 price target below current levels, indicating near-term caution despite long-term growth prospects in genomics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
